bg505 sosip gt1.1 gp140 vaccine
Vaccineexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 31, 2020 (NCT04224701)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, active
Human immunodeficiency virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04224701 | Phase 1 | Jan 31, 2020 | George Washington University, GlaxoSmithKline, International AIDS Vaccine Initiative, Rockefeller University, University of Amsterdam |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| George Washington University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| GlaxoSmithKline | For profit | 1 | 0 | 1 | 2020 |
| International AIDS Vaccine Initiative | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Rockefeller University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| University of Amsterdam | Academic/Hospital | 1 | 0 | 1 | 2020 |
5 organizations
Page 1 / 1